1[1]Miep H,Helfrich,Deborah et al. Expression of nitric oxide synthase isoformas in bone and bone cell cultures. J Bone Miner Res,1997;12(7):1108～1112
2[2]Mancini L,Moradi N,Brandi ML et al. Nitric oxide superoxide and peroxynitrite modulate osteoclast activity. Biochem Biophys Res Commun,1998;243(3):785～790
3[3]Robert J,De Marco G,Gangula P et al. Cytokine induced Ni- tric oxide inhibits bone resorption by inducing apoptosis of os- teoclast progenitors and suppressing osteoclast activity. J Bone Miner Res,1997;12(11):1797～1801
4[4]Evans DM,Ralston SH. Nitric oxide and bone. J Bone Miner Res,1996;11(3):300～305
5[5]Turner CH,Owan I,Jacob DS et al. Effects of nitric oxide synth ase inhibitors on bone formation in rats. Bone,1997;21(6):487～490
6[6]Kiodrung MB. Skeletal tissue response to cytokines. Clin Orthop, 1990;258(3):245～278
7[7]Ralston SH. The Michael Mason Prize Essay 1997,Nitric ox- ide and bone what a gas. Br J Rheumatol,1997;36(8):831～838
8[8]Mancini L,Becherini L,Benvenuti S et al. Bioeffects of a nit- ric oxide donor in a human preosteoclastic cell line. Int J Clin Pharmacol Res,1997;17(1):2～7
9[9]Roodman CD. Application of bone marrow cultures to the study of osteoclast formation and osteoclast precursors in man. Calcif Tissue Int,1995;56(Suppl l):22～23
10[10]Kikkawa I,Satio S,Tominaga K et al. Lipopolysaccharide (LPS) stimulates the production of tumor necrosis factor (TNF)-alpha and expression of inducible nitric oxide synthase (iNOS) by osteoclasts in murine bone marrow cell culture. Microbiol Im-munol,1998;42(9):591～598
1Soto AM, Sonnenschein C, Chung KL. The E-screen assay as a tool to identify estrogens:An update on estrogenic environmental pollutants[J]. Environ Health Perspect, 1995, 103:113-122.
2Bail RM, Fang H, Branham WS, et al. The estrogen receptor relative binding affinities of 188 natural and xenochemicals:structural diversity of ligands[J]. Toxicol Sci, 2000, 54:138-153.
3Soule H, Vazquez J, Long A, et al. A human cell line from a pleural effusion derived from a breast carcinoma[J]. J Natl Cancer Inst, 1973, 51:1409-1431.
4Shelby MD. Assessing environmental chemicals for estrogenicity using a combination of in vitro and in vivo assays[J]. Environ Health Perspect, 1996, 104:1296-1300.
5Johri RK, Pahwa GS, Sharma SC, et al. Determination of estrogenic/antiestrogenic potential of antifertility substances using rat uterine peroxidase assay[J]. Contraception, 1991, 44(5):549-557.
6Thomas P, Smith J. Binding of xenobiotics to the estrogen receptor of spotted seatrout:a screening assay for potential estrogenic effects[J]. Mar Environ Res, 1993, 35:147-151.
7吴景兰 丁一.实用非放射性分子生物学实验技术[M].郑州:河南医科大学出版社,1996.144.
8Gerhard M,Ganz P.How do we explain the clinical benefits of estrogen[J] Circulation,1995,92:5-9
9T. Pelzer,A. Shamim,L. Neyses. Estrogen effects in the heart[J] 1996,Molecular and Cellular Biochemistry(1):307～313
